Literature DB >> 2512511

G protein dependent alterations in [125I]iodocyanopindolol and +/- cyanopindolol binding at 5-HT1B binding sites in rat brain membranes.

K Ariani1, M W Hamblin, G L Tan, C A Stratford, R D Ciaranello.   

Abstract

Several manipulations that affect G protein/receptor coupling also alter the binding of [125I]iodocyanopindolol ([125I]ICYP) and [corrected] +/- cyanopindolol (+/- CYP) to rat brain 5-HT1B binding sites in radioligand binding assays. Inclusion of 5 mM MgSO4 in these assays results in a small but significant increase in the affinity of [125I]ICYP (from KD = 0.046 nM to KD = 0.037 nM). In contrast, 100 microM Gpp(NH)p, GTP, or GDP reduce [125I]ICYP affinity (KD = 0.056 nM with GTP) while ATP and GMP are less effective. +/- CYP affinity for 5-HT1B sites labeled by [3H]dihydroergotamine [( 3H]DE) also displays a small but significant reduction (from Ki = 1.4 nM to Ki = 3.5nM) by the inclusion of 100 microM GTP. Pre-treatment of the brain membranes with N-ethylmaleimide (NEM) in concentrations known to inactivate many G proteins reduces 5-HT1B specific binding of [125I]ICYP. The NEM induced reduction in [125I]ICYP binding can be reversed by reconstitution with purified exogenous G proteins (Go and Gi), demonstrating directly that high affinity binding of [125I]ICYP to 5-HT1B sites is dependent on G proteins. The effects of Mg2+ ion, guanine nucleotides, NEM and G protein reconstitution on [125I]ICYP and +/- CYP binding are all hallmarks of agonist binding to G protein linked receptors. The effect of GTP, however, is quantitatively much less for the binding of these pindolol derivatives than for the binding of 5-HT, a presumed full agonist at 5-HT1B sites.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2512511     DOI: 10.1007/bf00964812

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  37 in total

1.  [3H]dihydroergotamine as a high-affinity, slowly dissociating radioligand for 5-HT1B binding sites in rat brain membranes: evidence for guanine nucleotide regulation of agonist affinity states.

Authors:  M W Hamblin; K Ariani; P I Adriaenssens; R D Ciaranello
Journal:  J Pharmacol Exp Ther       Date:  1987-12       Impact factor: 4.030

2.  Magnesium dependence of agonist binding to adenylate cyclase-coupled hormone receptors.

Authors:  L T Williams; D Mullikin; R J Lefkowitz
Journal:  J Biol Chem       Date:  1978-05-10       Impact factor: 5.157

3.  Characterization of the 5-HT1B recognition site in rat brain: binding studies with (-)[125I]iodocyanopindolol.

Authors:  D Hoyer; G Engel; H O Kalkman
Journal:  Eur J Pharmacol       Date:  1985-11-26       Impact factor: 4.432

4.  Application of [125I]iodocyanopindolol to measure 5-hydroxytryptamine1B receptors in the brain of the rat.

Authors:  S J Offord; G A Ordway; A Frazer
Journal:  J Pharmacol Exp Ther       Date:  1988-01       Impact factor: 4.030

5.  Analysis of radioligand binding experiments. A collection of computer programs for the IBM PC.

Authors:  G A McPherson
Journal:  J Pharmacol Methods       Date:  1985-11

6.  Serotonin receptor binding sites affected differentially by guanine nucleotides.

Authors:  S J Peroutka; R M Lebovitz; S H Snyder
Journal:  Mol Pharmacol       Date:  1979-11       Impact factor: 4.436

7.  Cyanopindolol is a highly potent and selective antagonist at the presynaptic serotonin autoreceptor in the rat brain cortex.

Authors:  E Schlicker; M Göthert; K Hillenbrand
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-12       Impact factor: 3.000

8.  (-)-Propranolol and (+/-)-cyanopindolol are mixed agonists-antagonists at serotonin autoreceptors in the hippocampus of the rat brain.

Authors:  G Maura; M Ulivi; M Raiteri
Journal:  Neuropharmacology       Date:  1987-07       Impact factor: 5.250

9.  Isolation of two proteins with high affinity for guanine nucleotides from membranes of bovine brain.

Authors:  P C Sternweis; J D Robishaw
Journal:  J Biol Chem       Date:  1984-11-25       Impact factor: 5.157

10.  Differential inactivation and G protein reconstitution of subtypes of [3H]5-hydroxytryptamine binding sites in brain.

Authors:  C A Stratford; G L Tan; M W Hamblin; R D Ciaranello
Journal:  Mol Pharmacol       Date:  1988-10       Impact factor: 4.436

View more
  1 in total

1.  Alkylation of [3H]8-OH-DPAT binding sites in rat cerebral cortex and hippocampus.

Authors:  E K Nénonéné; F Radja; M Carli; N M van Gelder; S Afkhami-Dastjerdian; T A Reader
Journal:  Neurochem Res       Date:  1996-02       Impact factor: 3.996

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.